| Narcolepsy—clinical spectrum, aetiopathophysiology, diagnosis and treatment CLA Bassetti, A Adamantidis, D Burdakov, F Han, S Gay, U Kallweit, ... Nature Reviews Neurology 15 (9), 519-539, 2019 | 441 | 2019 |
| T cells in patients with narcolepsy target self-antigens of hypocretin neurons D Latorre, U Kallweit, E Armentani, M Foglierini, F Mele, A Cassotta, ... Nature 562 (7725), 63-68, 2018 | 275 | 2018 |
| European guideline and expert statements on the management of narcolepsy in adults and children CLA Bassetti, U Kallweit, L Vignatelli, G Plazzi, M Lecendreux, E Baldin, ... European journal of neurology 28 (9), 2815-2830, 2021 | 152 | 2021 |
| Diagnosis of central disorders of hypersomnolence: a reappraisal by European experts GJ Lammers, CLA Bassetti, L Dolenc-Groselj, PJ Jennum, U Kallweit, ... Sleep medicine reviews 52, 101306, 2020 | 139 | 2020 |
| Pharmacological management of narcolepsy with and without cataplexy U Kallweit, CL Bassetti Expert opinion on pharmacotherapy 18 (8), 809-817, 2017 | 74 | 2017 |
| Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines–Multi-country assessment D Weibel, M Sturkenboom, S Black, M de Ridder, C Dodd, J Bonhoeffer, ... Vaccine 36 (41), 6202-6211, 2018 | 71 | 2018 |
| Is preeclampsia associated with restless legs syndrome? JO Ramirez, SAS Cabrera, H Hidalgo, SG Cabrera, M Linnebank, ... Sleep medicine 14 (9), 894-896, 2013 | 69 | 2013 |
| Continuous positive airway pressure therapy is effective for migraines in sleep apnea syndrome U Kallweit, H Hidalgo, V Uhl, PS Sándor Neurology 76 (13), 1189-1191, 2011 | 48 | 2011 |
| Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? U Kallweit, CR Baumann, M Harzheim, H Hidalgo, D Pöhlau, CL Bassetti, ... Multiple sclerosis international 2013, 2013 | 46 | 2013 |
| Cerebral hemodynamic changes in stroke during sleep-disordered breathing F Pizza, M Biallas, U Kallweit, M Wolf, CL Bassetti Stroke 43 (7), 1951-1953, 2012 | 45 | 2012 |
| Coexisting narcolepsy (with and without cataplexy) and multiple sclerosis: six new cases and a literature review U Kallweit, CLA Bassetti, M Oberholzer, R Fronczek, M Béguin, M Strub, ... Journal of neurology 265, 2071-2078, 2018 | 41 | 2018 |
| Excessive daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment U Kallweit, MM Siccoli, R Poryazova, E Werth, CL Bassetti European neurology 62 (3), 176-179, 2009 | 40 | 2009 |
| Elevated CSF histamine levels in multiple sclerosis patients U Kallweit, K Aritake, CL Bassetti, S Blumenthal, O Hayaishi, M Linnebank, ... Fluids and Barriers of the CNS 10, 1-3, 2013 | 32 | 2013 |
| Sustained efficacy of natalizumab in the treatment of relapsing-remitting multiple sclerosis independent of disease activity and disability at baseline: real-life data from a … U Kallweit, I Jelcic, N Braun, H Fischer, B Zörner, B Schreiner, AA Sokolov, ... Clinical neuropharmacology 35 (2), 77-80, 2012 | 32 | 2012 |
| The presence of oligoclonal IgG bands in human CSF during the course of neurological diseases M Haertle, U Kallweit, M Weller, M Linnebank Journal of neurology 261, 554-560, 2014 | 31 | 2014 |
| Pramipexole versus dual release levodopa in restless legs syndrome: a double blind, randomised, cross-over trial CL Bassetti, F Bornatico, P Fuhr, J Schwander, U Kallweit, J Mathis Swiss medical weekly 141, w13274, 2011 | 28 | 2011 |
| Successful treatment of methicillin-resistant Staphylococcus aureus meningitis using linezolid without removal of intrathecal infusion pump: case report U Kallweit, M Harzheim, G Marklein, T Welt, D Pöhlau Journal of neurosurgery 107 (3), 651-653, 2007 | 28 | 2007 |
| Patient-reported measures of narcolepsy: the need for better assessment U Kallweit, M Schmidt, CL Bassetti Journal of clinical sleep medicine 13 (5), 737-744, 2017 | 27 | 2017 |
| Sodium oxybate in narcolepsy with cataplexy: Zurich sleep center experience R Poryazova, S Tartarotti, R Khatami, CR Baumann, P Valko, U Kallweit, ... European neurology 65 (3), 175-182, 2011 | 27 | 2011 |
| Cystatin F is a biomarker of prion pathogenesis in mice M Nuvolone, N Schmid, G Miele, S Sorce, R Moos, C Schori, RR Beerli, ... PLoS One 12 (2), e0171923, 2017 | 26 | 2017 |
